Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH

ConditionPost Partum Haemorrhage

Trial statusNot yet recruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexFemale

Age18-45

SponsorSultan Qaboos University

About this trial

Investigating the efficacy of tranexamic acid (TXA) as a prophylactic agent in reducing postpartum haemorrhage (PPH) among patients undergoing cesarean section (CS) in SQUH: a prospective randomized controlled trial.

Eligibility criteria

Qualifiers

Previous Caesarean Section

Multiple pregnancy,

Polyhydramnios,

Fetal macrosomia (BW >4kg),

Disqualifiers

Placenta accreta spectrum,

Contraindications to tranexamic acid (e.g., hypersensitivity to tranexamic acid), -History of seizure disorders,

Kidney disease,

Thromboembolic disease,

Trial design

Treatments tested in this trial

tranexamic acid (1 g diluted in 100 mL of 0.9% saline
Normal (0.9%) saline

Treatment groups

88 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Sultan Qaboos University

Lead sponsor

Source ClinicalTrials.gov